Back
Pliant Therapeutics Vs. Amphastar Pharmaceuticals Industry Stock Comparison
Sell
39
PLRX
Pliant Therapeutics
Last Price:
12.84
Seasonality Move:
-10.54%
Buy
60
AMPH
Amphastar Pharmaceuticals
Last Price:
49.64
Seasonality Move:
6.34%
Sell
39
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $12.50. The Score for PLRX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- PLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Amphastar Pharmaceuticals (AMPH)
is a Buy
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
- The current Amphastar Pharmaceuticals [AMPH] share price is $49.78. The Score for AMPH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- AMPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $12.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight selling pressure.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals's stock price today?
-
The Amphastar Pharmaceuticals share price today is $49.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 47.82 | Sell |
| Chaikin Money Flow: | -29258 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.29 - 13.37) | Sell |
| Bollinger Bands (100): | (11.45 - 13.77) | Sell |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 67.72 | Buy |
| Chaikin Money Flow: | 301332 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.06 - 48.58) | Buy |
| Bollinger Bands (100): | (39.58 - 45.56) | Buy |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.37 | Buy |
| 20-day SMA: | 12.84 | Sell |
| 50-day SMA: | 12.88 | Sell |
| 200-day SMA: | 14.25 | Sell |
| 8-day EMA: | 12.42 | Buy |
| 20-day EMA: | 12.64 | Sell |
| 50-day EMA: | 12.71 | Sell |
| 200-day EMA: | 14.07 | Sell |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.92 | Buy |
| 20-day SMA: | 47.25 | Buy |
| 50-day SMA: | 43.91 | Buy |
| 200-day SMA: | 46.85 | Buy |
| 8-day EMA: | 47.77 | Buy |
| 20-day EMA: | 46.73 | Buy |
| 50-day EMA: | 44.86 | Buy |
| 200-day EMA: | 45.01 | Buy |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.32 per share.
Amphastar Pharmaceuticals Earnings Growth & AMPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.25 per share, an increase this year of $0.57 per share, and an increase next year of $0.39 per share.
Pliant Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||